SOLIGENIX, INC. Non Peo Neo Avg Total Comp Amt
SOLIGENIX, INC. (SNGX) reported Non Peo Neo Avg Total Comp Amt of $420.55 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-08-03.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-08-03
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $420.55K DEF 14A · filed 2026-08-03 |
| 2024-12-31 | $366.65K DEF 14A · filed 2026-08-03 |
| 2023-12-31 | $330.74K DEF 14A · filed 2026-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |